Search

everythinglearnresearchcommunity

for

Search:↓

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

New therapies are being developed that target integrin pathways to treat various diseases.

Healthy scalp reduces hair loss by managing oxidative stress.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Some drugs can cause changes to your hair.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

*Acorus calamus* has many medicinal benefits but needs more safety research.

UV-B light increases inflammation-related substances in acne-related skin cells.

Polymeric nanoparticles show promise for treating skin diseases.

A 55-year-old woman with several health conditions did not see hair regrowth after a transplant.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

No single biomarker is reliable enough for diagnosing and assessing SLE.